Short answer
Zoetis (ZTS) filed an 8-K current report with the SEC on August 6, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item EX-99.1 (Exhibit EX-99.1). James Saccaro appointed CFO and COO effective August 17, 2026, combining financial leadership with Global Manufacturing and Supply oversight.
Zoetis 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- James Saccaro appointed CFO and COO effective August 17, 2026, combining financial leadership with Global Manufacturing and Supply oversight
- Saccaro brings CFO experience from GE HealthCare and Baxter, supporting continuity in finance and operational execution
- Compensation includes $1,000,000 salary, 100% target bonus, and $5,000,000 annual long-term incentive opportunity
- One-time make-whole awards total $7,500,000, comprising $6,250,000 restricted stock units and $1,250,000 cash
- Wetteny Joseph transitions from CFO after August 16, 2026, remaining as a non-executive officer through February 28, 2027, with no reported disagreements
Item EX-99.1 · Exhibit EX-99.1
- Jay Saccaro appointed CFO and COO effective August 17, 2026
- Newly combined role oversees finance, capital allocation, reporting, controls, investor engagement, manufacturing, and supply
- Wetteny Joseph transitions to Special Advisor to the CEO through early 2027, supporting continuity during CFO succession
- Saccaro brings 12 years of CFO experience and prior margin, cash-flow, capital-allocation, and M&A leadership
- Expanded finance-and-operations mandate signals focus on execution, supply-chain performance, and innovation-funded growth
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Zoetis 8-K filings
Get the next ZTS 8-K as it lands
Follow ZTS for push alerts, or ask the research agent what this filing means.